Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-032563)

Filing Details

Accession Number:: 0001209191-18-032563
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-23 16:06:28
Reporting Period:: 2018-05-21

Accepted Time:: 2018-05-23 16:06:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488613	Foundation Medicine Inc.	FMI	Services-Medical Laboratories (8071)	271316416

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1584999	A. Vincent Miller	150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-21	1,570	$29.94	71,658	No	4	M	Direct
Common Stock	Disposition	2018-05-21	1,570	$85.00	70,088	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2018-05-21	1,570	$0.00	1,570	$29.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2024-04-09	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
This stock option was granted on April 9, 2014 and vested in equal quarterly installments beginning on June 30, 2014 until fully vested on March 31, 2018.